Just again about targeted medicine. I have found a real masterpiece about this issue:
The study showed the newer cancer drugs caused significantly more side effects, and more treatment-related deaths, than their older counterparts. "You've got to consider both efficacy and toxicity in the picture," said Susan Ellenberg, who has studied drug side effects at the University of Pennsylvania's Perelman School of Medicine.
Well, I am completely lost: we were told that targeted medicines a priori (due to they ARE targeted) are more efficient and LESS toxic compared to non-targeted ones! Somebody has to help me in connecting the dots!
No comments:
Post a Comment